ORIC Pharmaceuticals, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.00 |
0.00 |
8.22 |
4.30 |
28.79 |
83.29 |
| Przychód Δ r/r |
0.00% |
0.00% |
inf% |
-47.66% |
569.33% |
189.35% |
| Przychód (min) |
0.00 |
0.00 |
8.22 |
4.30 |
28.79 |
83.29 |
| Przychód (max) |
0.00 |
0.00 |
8.22 |
4.30 |
28.79 |
83.29 |
| EBITDA (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT % |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Zysk netto (średni) |
-129.13 |
-122.00 |
-117.47 |
-113.71 |
-113.94 |
-92.04 |
| Zysk netto % |
-inf% |
-inf% |
-1429.72% |
-2644.12% |
-395.81% |
-110.50% |
| EPS (średnia) |
-1.85 |
-1.75 |
-1.74 |
-1.66 |
-1.63 |
-1.32 |
| Liczba analityków (Przychody) |
0 |
0 |
12 |
8 |
6 |
7 |
| Liczba analityków (EPS) |
9 |
9 |
11 |
6 |
3 |
4 |
| symbol |
ORIC |
ORIC |
ORIC |
ORIC |
ORIC |
ORIC |